{"id":9564,"date":"2026-02-21T22:08:50","date_gmt":"2026-02-21T19:08:50","guid":{"rendered":"https:\/\/jordan-cardiac.org\/?p=9564"},"modified":"2026-02-21T22:08:50","modified_gmt":"2026-02-21T19:08:50","slug":"endovascular-treatment-for-long-femoropopliteal-lesions-meta-analysis-2026","status":"publish","type":"post","link":"https:\/\/jordan-cardiac.org\/en\/endovascular-treatment-for-long-femoropopliteal-lesions-meta-analysis-2026\/","title":{"rendered":"Endovascular Treatment for Long Femoropopliteal Lesions \u2013 Meta-Analysis (2026)"},"content":{"rendered":"<div>Endovascular Treatment for Long Femoropopliteal Lesions \u2013 Meta-Analysis (2026)<\/div>\n<div><\/div>\n<div><span> \u2022 Terminology note: PCI refers specifically to coronary intervention; femoropopliteal procedures are classified as peripheral endovascular revascularization.<\/span><\/div>\n<div><span> \u2022 Surgical bypass remains the gold standard for long femoropopliteal lesions.<\/span><\/div>\n<div><span> \u2022 A large meta-analysis supports an expanding role for less invasive revascularization strategies.<\/span><\/div>\n<div><span> \u2022 Newer technologies (drug-eluting stents, covered stents, drug-coated balloons) are associated with improved outcomes.<\/span><\/div>\n<div><span> \u2022 Results have improved in recent years with better devices and greater operator experience.<\/span><\/div>\n<div><span> \u2022 Particularly relevant in patients at high surgical risk.<\/span><\/div>\n<div><\/div>\n<div>Source &amp; Date: Study published in JSCAI \u2013 16 January 2026<\/div>\n<div><\/div>\n<div><a href=\"https:\/\/www.jscai.org\/article\/S2772-9303(25)01604-7\/fulltext#tbl2\">https:\/\/www.jscai.org\/article\/S2772-9303(25)01604-7\/fulltext#tbl2<\/a><\/div>\n<div><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Endovascular Treatment for Long Femoropopliteal Lesions \u2013 Meta-Analysis (2026) \u2022 Terminology note: PCI refers specifically to coronary intervention; femoropopliteal procedures are classified as peripheral endovascular revascularization. \u2022 Surgical bypass remains the gold standard for long femoropopliteal lesions. \u2022 A large meta-analysis supports an expanding role for less invasive revascularization strategies. \u2022 Newer technologies (drug-eluting stents, [&hellip;]<\/p>\n","protected":false},"author":145,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-9564","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/9564","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/users\/145"}],"replies":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/comments?post=9564"}],"version-history":[{"count":1,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/9564\/revisions"}],"predecessor-version":[{"id":9565,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/9564\/revisions\/9565"}],"wp:attachment":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/media?parent=9564"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/categories?post=9564"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/tags?post=9564"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}